BioRegenx, Inc.
BRGX
$0.008
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -18.40M | -394.90K | -3.55M | -704.80K | -256.70K |
| Total Depreciation and Amortization | 574.50K | 574.50K | 870.20K | 200.10K | 1.20K |
| Total Amortization of Deferred Charges | 14.30K | 8.60K | 24.80K | -- | -- |
| Total Other Non-Cash Items | 17.66M | -260.50K | 2.20M | 330.20K | 263.40K |
| Change in Net Operating Assets | 139.60K | 41.10K | 138.30K | 211.60K | -253.40K |
| Cash from Operations | -11.40K | -31.20K | -318.60K | 37.00K | -245.60K |
| Capital Expenditure | 0.00 | 0.00 | 399.00K | -588.40K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | 1.40K | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.70K | 0.00 | 18.45M | -18.45M | -199.40K |
| Cash from Investing | 2.70K | 0.00 | 18.85M | -19.04M | -199.40K |
| Total Debt Issued | 1.50K | 56.80K | -205.50K | 637.50K | 2.60K |
| Total Debt Repaid | -8.50K | -10.30K | 62.00K | -91.50K | -16.40K |
| Issuance of Common Stock | -- | -- | -- | -- | 527.10K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -18.44M | 18.44M | -- |
| Cash from Financing | -6.90K | 46.40K | -18.58M | 18.99M | 513.40K |
| Foreign Exchange rate Adjustments | 4.00K | -2.60K | 500.00 | 1.00K | -900.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.70K | 12.70K | -56.80K | -11.20K | 67.40K |